Literature DB >> 35226170

Catecholamines' accumulation and their disturbed metabolism at perilesional site: a possible cause of vitiligo progression.

Sushma Tanwar1, Vishal Thakur1, Alka Bhatia2, Davinder Parsad3.   

Abstract

Catecholamines (epinephrine, norepinephrine and dopamine) are considered toxic to the melanocytes and may play an important role in the development of depigmented patches on the skin. This study was done to evaluate the levels of catecholamines in skin and plasma samples of active vitiligo patients' and gene expression changes in catecholamines' metabolism regulatory genes (COMT and GTPCH1), immunoregulatory genes (CTLA4 and PTPN22), and Catalase in active vitiligo patients. In this single-centre, prospective, case-control study, 30 patients with active vitiligo were recruited and skin biopsies from the perilesional site and plasma samples were collected. Skin biopsies from the normal site in vitiligo patients and healthy controls (n = 15) and plasma samples from controls were also obtained. Catecholamines' estimation was done via high-performance liquid chromatography. Gene expression variations were investigated via reverse transcription-polymerase chain reaction (PCR) and real-time PCR. Epinephrine, norepinephrine and dopamine levels were significantly higher in perilesional skin biopsies as compared to controls (P = 0.035, 0.024, and 0.006, respectively). However, epinephrine, norepinephrine and dopamine levels observed in patients' plasma samples were comparable to controls. The mRNA expression level of the Catalase gene was found to be upregulated at the perilesional site of patients as compared to the non-affected site of same patients (P < 0.001) and healthy controls (P = 0.037). Transcriptional expression of GTPCH1 and COMT were observed to be increased significantly at the perilesional site of patients in comparison to controls (P = 0.004 and P = 0.046, respectively). Our results support the presence of oxidative stress, inflammation and induced immune response in vitiligo patients at the perilesional sites. The increased inflammatory response may lead to catecholamines upregulation resulting in oxidative stress and melanocyte damage.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Catecholamines; Inflammation; Oxidative stress; Vitiligo

Year:  2022        PMID: 35226170     DOI: 10.1007/s00403-022-02333-3

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  20 in total

Review 1.  A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?

Authors:  Yvon Gauthier; Muriel Cario Andre; Alain Taïeb
Journal:  Pigment Cell Res       Date:  2003-08

Review 2.  Vitiligo Pathogenesis and Emerging Treatments.

Authors:  Mehdi Rashighi; John E Harris
Journal:  Dermatol Clin       Date:  2017-04       Impact factor: 3.478

3.  CTLA-4 can function as a negative regulator of T cell activation.

Authors:  T L Walunas; D J Lenschow; C Y Bakker; P S Linsley; G J Freeman; J M Green; C B Thompson; J A Bluestone
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

4.  Promoter variant in the catalase gene is associated with vitiligo in Chinese people.

Authors:  Ling Liu; Chunying Li; Jian Gao; Kai Li; Rui Zhang; Gang Wang; Chenxin Li; Tianwen Gao
Journal:  J Invest Dermatol       Date:  2010-07-08       Impact factor: 8.551

5.  Cytokines stimulate GTP cyclohydrolase I gene expression in cultured human umbilical vein endothelial cells.

Authors:  Z S Katusic; A Stelter; S Milstien
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-01       Impact factor: 8.311

6.  Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis.

Authors:  K Steiner; F Moosig; E Csernok; K Selleng; W L Gross; B Fleischer; B M Bröker
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

7.  Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes.

Authors:  Mary Rieck; Adrian Arechiga; Suna Onengut-Gumuscu; Carla Greenbaum; Patrick Concannon; Jane H Buckner
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

8.  Interleukin-6 increases intracellular Ca2+ concentration and induces catecholamine secretion in rat carotid body glomus cells.

Authors:  Juan Fan; Bo Zhang; Hai-Feng Shu; Xiao-Yu Zhang; Xi Wang; Fang Kuang; Ling Liu; Zheng-Wu Peng; Rui Wu; Zhuan Zhou; Bai-Ren Wang
Journal:  J Neurosci Res       Date:  2009-09       Impact factor: 4.164

9.  A functional single-nucleotide polymorphism in the catechol-O-methyltransferase gene alter vitiligo risk in a Chinese population.

Authors:  Kai Li; Chunying Li; Lin Gao; Li Yang; Miao Li; Ling Liu; Zhengdong Zhang; Yufeng Liu; Tianwen Gao
Journal:  Arch Dermatol Res       Date:  2008-12-28       Impact factor: 3.017

10.  Characterization of NF-kB-mediated inhibition of catechol-O-methyltransferase.

Authors:  Inna E Tchivileva; Andrea G Nackley; Li Qian; Sean Wentworth; Matthew Conrad; Luda B Diatchenko
Journal:  Mol Pain       Date:  2009-03-16       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.